CBD Life Sciences Inc.

CBDLOTCHealthcare● Active

$0.00

$-0.00(-16.67%)

Market Cap$469243

P/E Ratio—

52W High$0.001

52W Low$0.0001

Avg Volume24.6M

Open$0.00

Beta-3603.52

Overview

CBD Life Sciences Inc. (CBDL) Revenue

Annual & quarterly revenue history · segment & region breakdown

CBDL · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

CBD Life Sciences Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

6.60×

mktCap ÷ TTM rev

Revenue per day

$0M

Est. TTM ÷ 365

Revenue / employee

$24K

3 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · CBD Life Sciences Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

CBDL revenue by year · CBDL revenue history · CBDL annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income CBD Life Sciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

CBD Life Sciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from CBD Life Sciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

CBDL revenue · 4 questions

CBDL's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CBDL revenueCBDL annual revenuewhat is CBDL revenueCBDL TTM revenue

▸ Source: FMP · CBD Life Sciences Inc. SEC filings · GAAP · CBD Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026